Melt-Curve Analysis and Epigenetic Detection

Overview

This lesson pairs two techniques that sit alongside the core amplification and sequencing workflows. The first, melt-curve analysis, is a simple add-on to real-time PCR that reports on the identity and purity of an amplified product. The second, epigenetic modification detection, is a family of methods aimed at a layer of information that the bare sequence does not capture: chemical marks on the DNA. Both build directly on ideas introduced earlier — the melting temperature of a duplex, complementary base pairing, real-time PCR, bisulfite conversion, and chromatin methylation — and this lesson assumes those are familiar rather than re-teaching them.

Melt-Curve Analysis

Melt-curve (or dissociation) analysis is performed at the end of a real-time PCR run, after amplification is complete. Instead of cycling the temperature, the instrument slowly and continuously heats the reaction — typically over a span such as 60 to 95 degrees Celsius — while monitoring fluorescence the whole way up ¹. The fluorescent signal comes either from a double-strand-binding intercalating dye or from sequence-specific probes that report only while bound to their target.

The principle rests entirely on the melting temperature concept established for base pairing. While the amplicon stays double-stranded, dye remains intercalated and fluorescence is high. As the temperature climbs through the duplex’s Tm — the point at which half the molecules have separated — the strands come apart, the dye is released, and fluorescence drops sharply ¹. A raw plot of fluorescence versus temperature therefore shows a steep downward step at the Tm.

To read the transition more precisely, the software plots the negative first derivative of fluorescence with respect to temperature (often written -dF/dT). The steep drop in the raw curve becomes a clear melt peak, and the temperature at the top of that peak is the product’s Tm.

  Raw melt curve                 Negative derivative (-dF/dT)
  Fluorescence                   Rate of change
   |‾‾‾‾‾\                          |        peak (Tm)
   |     \                          |        /\
   |      \                         |       /  \
   |       \___                     |   ___/    \___
   +-------------- Temp -->         +-------------------- Temp -->
        ^ Tm                                 ^ Tm
   (sharp drop as duplex melts)     (drop becomes a peak at the Tm)

The shape and position of the peak carry useful information. Because Tm rises with higher GC content and with greater length, different sequences melt at different, predictable temperatures. The most common everyday use is a quality check: a single, sharp peak at the expected Tm indicates one specific product, whereas extra peaks at lower temperatures flag primer-dimers or other short, nonspecific products that melt earlier than the intended amplicon ¹. This makes melt analysis a low-cost alternative to running a gel just to confirm specificity.

High-Resolution Melt (HRM)

High-resolution melt extends the same idea with finer temperature control, specialized saturating dyes, and more data points per degree, so that very small Tm differences become measurable ¹. Where ordinary melt analysis asks “is this the right product?”, HRM asks “which version of the product is this?” — distinguishing genotypes and variants by tiny shifts in melting behavior.

A single-nucleotide change, for example, alters the amplicon’s Tm slightly, so a wild-type and a variant homozygote produce peaks at marginally different temperatures. Heterozygotes are even more distinctive: when both alleles are present, the denatured strands can re-anneal into mismatched heteroduplexes as well as matched homoduplexes. The mismatched duplexes are less stable and melt earlier, so a heterozygote yields a characteristically altered curve shape rather than a simple shift in peak position ¹. HRM is also widely used after bisulfite treatment to separate methylated from unmethylated templates, which differ in sequence and therefore in Tm.

Epigenetic Modification Detection

Epigenetics refers to heritable changes in gene activity that do not alter the underlying DNA sequence. In clinical molecular testing, the dominant mark is DNA methylation — the addition of a methyl group to cytosine, almost always at cytosine-guanine (CpG) sites. The chemistry of this mark and the way bisulfite conversion is used to read it were covered in the chromatin and bisulfite lessons; the focus here is how that mark is detected in practice.

Because methylation is invisible to ordinary sequence reading, every detection strategy must first turn the methyl mark into something a method can see. Three broad routes are used:

• Bisulfite conversion followed by a readout. Bisulfite treatment converts unmethylated cytosines to uracil while leaving methylated cytosines unchanged, so methylation status becomes a sequence difference. That converted template can then be interrogated by methylation-specific PCR (MSP) with primers designed to match either the methylated or unmethylated sequence, by HRM exploiting the resulting Tm difference, by pyrosequencing for position-by-position quantitation, or by direct sequencing ¹.
• Methylation-sensitive restriction enzymes. Certain restriction enzymes cut their recognition site only when it is unmethylated and are blocked when the site is methylated. Comparing whether a site is cut therefore reveals its methylation state ².
• Methylation arrays. Microarrays interrogate many CpG sites across the genome at once, giving a genome-scale methylation profile at a high level.

Why methylation matters clinically is best seen through two broad categories, each developed in its own lesson elsewhere in the program. In cancer, abnormal methylation of the promoter of a tumor-suppressor gene can switch that gene off — silencing a protective function without changing a single base — a theme that recurs in the oncology material. In imprinting disorders, the parent of origin of an allele is normally distinguished by methylation, and faults in that pattern underlie conditions covered later, such as Prader-Willi and Angelman syndromes ³. In both settings the diagnostic question is not what the sequence is, but how it is marked.

Why These Techniques Matter

Melt-curve analysis and epigenetic detection round out the amplification toolkit by reading information the basic PCR product does not, on its own, reveal. A melt peak confirms that an amplification produced the one intended duplex and, in its high-resolution form, can tell closely related sequences apart by fractions of a degree. Methylation detection reaches past the sequence itself to the chemical annotations layered on top of it. Both depend on the same physical foundation — the predictable way a duplex’s stability and melting behavior follow from its sequence — and both feed directly into the clinical applications, from variant genotyping to oncology and imprinting, taken up in later lessons.